A detailed history of Ethic Inc. transactions in Agenus Inc stock. As of the latest transaction made, Ethic Inc. holds 70,616 shares of AGEN stock, worth $1.18 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
70,616
Holding current value
$1.18 Million
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.69 - $16.69 $1.18 Million - $1.18 Million
70,616 New
70,616 $1.18 Million
Q1 2024

May 13, 2024

BUY
$0.53 - $0.93 $37,426 - $65,672
70,616 New
70,616 $40,000
Q3 2023

Nov 14, 2023

BUY
$1.12 - $1.88 $19,425 - $32,606
17,344 New
17,344 $19,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.